Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Craig Crosson and David Potter.
Connection Strength

0.492
  1. Pharmacological evidence for heterogeneity of ocular alpha 2 adrenoceptors. Curr Eye Res. 1992 Oct; 11(10):963-70.
    View in: PubMed
    Score: 0.108
  2. Prejunctional adrenoceptor activity of N-0437: a relatively selective DA2 dopamine receptor agonist. Eur J Pharmacol. 1990 Mar 27; 178(3):351-5.
    View in: PubMed
    Score: 0.090
  3. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction. J Ocul Pharmacol. 1990; 6(4):293-9.
    View in: PubMed
    Score: 0.089
  4. Opioid receptor-activation: retina protected from ischemic injury. Invest Ophthalmol Vis Sci. 2009 Aug; 50(8):3853-9.
    View in: PubMed
    Score: 0.084
  5. Ocular effects of a N,N-disubstituted 5-OH aminotetralin (N-0437): evidence for a dual mechanism of action. Curr Eye Res. 1987 Nov; 6(11):1319-26.
    View in: PubMed
    Score: 0.077
  6. Functional evidence for heterogeneity of ocular alpha 2-adrenoceptors. Proc West Pharmacol Soc. 1990; 33:257-60.
    View in: PubMed
    Score: 0.022
  7. Review: alpha 2 and DA2 agonists as antiglaucoma agents: comparative pharmacology and clinical potential. J Ocul Pharmacol. 1990; 6(3):251-7.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.